NCI Symposium on Mutation Signatures and Cancer: Future Directions
In the 6th session of the NCI Symposium on Mutation Signatures and Cancer, Dr. Maria Teresa Landi (NCI) and Dr. Ludmil Alexandrov (University of California, San Diego) moderate a panel discussion with symposium speakers about future directions for research focusing on mutation signatures in cancer.

▶︎
SWOG and Its Expansion into Latin America

▶︎
NCI Symposium on Mutation Signatures and Cancer: Opening Session

▶︎
The Zebrafish, Danio rerio

▶︎
Technology Innovation for Impact: Challenges & Opportunities in Global Cervical Cancer Prevention

▶︎
The Fruit Fly, Drosophila melanogaster

▶︎
Single Cell RNA-Seq Tool - Genomic Data Commons

▶︎
ASA24: Informes de alimentos, bebidas y suplementos

▶︎
Uncover Patterns in Genomic Variation Data with Clinical Phenotypes Using GDC Correlation Plot Tool

▶︎
The Worm, Caernorhabditis elegans

▶︎
The Stronger Together Program Pilot: Peer Support for Cancer in Low-Resource Settings

▶︎
Select Sessions from the 13th Annual Symposium on Global Cancer Research

▶︎
S3 Virtual Workshop Series: Tumor-Immune Interactions

▶︎
AutoRT: Deep Learning-Based Retention Time Prediction for Modified Peptides

▶︎
Proteomic Data Commons in Cancer Research

▶︎
ASA24: Reporting Foods, Drinks, and Dietary Supplements

▶︎
Exploring GDC Copy Number Variation (CNV) Analysis Workflows and Tools

▶︎
S3 Virtual Workshop Series: Drug Response and Resistance

▶︎
BayesDeBulk: A New Method for Bulk Deconvolution Based on Proteogenomic Data

▶︎
Quantification Workflows in FragPipe Computational Pipeline (Keynote)

▶︎
